Virtusa / Life Sciences / Contract Research Organizations
Bringing your drugs and devices to market faster

The trend of large pharmaceutical companies divesting parts of their R&D infrastructure for better cost containment, revenue growth, and shorter clinical trial cycles has increased business for Contract Research Organizations (CROs). However, these collaborative partnerships are creating a need for flexible arrangements and integrated end-to-end solutions. This is particularly true as companies are embracing adaptive study designs that require data visualization, analytics, and transparency across the clinical trial continuum. To be successful, CROs need to align their services to support their customers to efficiently navigate regulatory pathways and shorten the clinical trial lifecycle, all without compromising quality. By adopting unique technology solutions, CROs have the ability to develop reputations as leaders in moving new drugs and devices from conception to FDA/EMA marketing approval with limited sponsor dependence.

Our consultative and technology based solutions are here to meet your objectives:

Connected Care for Clinical Trials

A patient-centric platform to takes your trials to the next level

Connected Care for Clinical Trials

Our Connected Care platform offerings are the definition of patient-centricity. We help reduce your patients’ anxiety and confusion of choices, help them make informed decisions, and provide an overall better clinical trial experience through improved connected care coordination. In turn, your clinical trial ecosystem sees improved patient treatment adherence and has a minimized level of patient dropouts. Another benefit is increased volume and quality of data that allows researchers to make more informed R&D decisions. Connected Care is a key enabler for your goal achievement, serving as a centralized, secure, and compliant platform that is highly scalable and gives your patients the resources they need to stay committed to trial success.

Cognitive Pharmacovigilance (PV) Intake

Maximize your ability to identify and process adverse event scenarios

Cognitive Pharmacovigilance (PV) Intake

Our cloud-based, omni-channel solution proactively identifies and manages risk within a shifting compliance environment. This ground-breaking solution supports intake from devices, sensors, social media, and other intelligence channels, which alleviates reliance on voluntary patient and provider reporting. Standardized processes and analytics increase visibility into performance, improve operational efficiencies, avoid fines and increase the therapeutic value of your drug and device products

Cloud Migration

Enhance your scalability and efficiency with the cloud

Cloud Migration

Faced with growing pressure to bolster shrinking pipelines, accelerate innovation, streamline R&D and improve the rate of return, pharmaceutical companies are exploring new business models and technologies that can drive innovation, improve collaboration and accelerate new product development. Cloud computing is transforming most industry sectors across the world, and have had an intense impact on life sciences. The cloud—specifically, is the need of the hour to improve productivity and enable teams to collaborate more effectively. The savings and agility provided by cloud computing have solidified IT as vital to meeting the strategic ambitions of every enterprise. Whether or not a business has adopted cloud, its stakeholders are undoubtedly considering its potential to contribute not only to cost reduction, but also to the growth of the organization.